Sandra
Blanco Benavente
Hospital Universitario de Salamanca
Salamanca, EspañaPublicacións en colaboración con investigadores/as de Hospital Universitario de Salamanca (12)
2024
-
Exploring the role of ribosomal RNA modifications in cancer
Current Opinion in Genetics and Development, Vol. 86
-
Global and single-nucleotide resolution detection of 7-methylguanosine in RNA
RNA Biology, Vol. 21, Núm. 1, pp. 1-18
-
The impact of tRNA modifications on translation in cancer: identifying novel therapeutic avenues
NAR Cancer, Vol. 6, Núm. 1
2023
-
METTL1 promotes tumorigenesis through tRNA-derived fragment biogenesis in prostate cancer
Molecular cancer, Vol. 22, Núm. 1, pp. 119
-
N7-methylguanosine methylation of tRNAs regulates survival to stress in cancer
Oncogene, Vol. 42, Núm. 43, pp. 3169-3181
2022
-
Epigenetic and Epitranscriptomic Control in Prostate Cancer
Genes, Vol. 13, Núm. 2
2021
-
A therapy PUSh for GBM
Nature Cancer, Vol. 2, Núm. 9, pp. 876-878
-
The role of m6A, m5C and Ψ RNA modifications in cancer: Novel therapeutic opportunities
Molecular Cancer, Vol. 20, Núm. 1
2020
-
Glia Crosstalk in Neuroinflammatory Diseases
Frontiers in Cellular Neuroscience, Vol. 14
2014
-
Vaccinia-related kinase 1 (VRK1) confers resistance to DNA-damaging agents in human breast cancer by affecting dna damage response
Oncotarget, Vol. 5, Núm. 7, pp. 1770-1778
2013
-
Human VRK2 modulates apoptosis by interaction with Bcl-xL and regulation of BAX gene expression
Cell Death and Disease, Vol. 4, Núm. 2
2012
-
VRK2 anchors KSR1-MEK1 to endoplasmic reticulum forming a macromolecular complex that compartmentalizes MAPK signaling
Cellular and Molecular Life Sciences, Vol. 69, Núm. 22, pp. 3881-3893